SIGA
SIGA Technologies, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.29
+1.86%Aug 7, 2026, 12:05 UTC
Siga Technologies reported second-quarter product-related revenue of $38 million, driven by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to international customers.
Jun 10, 2026, 00:00 UTC
SIGA TECHNOLOGIES INC elected five new directors to its board on June 9, 2026.